High-Quality Screening and Target Validation During Drug Development

Drew Adams will discuss his work developing therapeutics that promote remyelination for neurological diseases.

The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific
Oct 18, 2021

LIVE Webinar

Thursday, October 28, 2021
2:30 - 3:30 PM Eastern Time

Register Now

As scientists search for new drug targets and screen for compounds to treat disease, they often run into roadblocks related to data quality. Researchers must use their expertise to circumvent these problems if they hope to rapidly develop high-quality, novel therapeutics. In this webinar sponsored by Thermo Fisher Scientific, Drew Adams will discuss his work identifying new targets and screening small molecules to develop therapeutics for neurological diseases, with an emphasis on resolving data quality problems.

Topics to be covered

  • Data quality in high-throughput screening and target validation
  • Validating new targets and small molecules targeting cholesterol biosynthesis to promote remyelination

Register Now

Meet the Speaker:

Drew Adams, PhD
Thomas F. Peterson Professor of Novel Therapeutics
Associate Professor, Genetics and Genome Sciences
Director, Small Molecule Drug Development Core
Case Western Reserve University School of Medicine

Sponsored By